The short version
23 companies supply this market — deep enough that no single failure threatens the supply. The generic price has held steady around $0.0301 per mL over the past year. The brand runs $1.92 per mL — 64× more.
Market view
levetiracetam · Solution
51 marketed package NDCs · 23 active manufacturers
Most dispensed: 1000 mg · Tablet, Film Coated · #60 tablet, film coateds/bottle · 500 mg · Tablet, Film Coated · #500 tablet, film coateds/bottle · 500 mg · Tablet, Film Coated · #120 tablet, film coateds/bottle · 250 mg · Tablet, Film Coated · #120 tablet, film coateds/bottle
Price range and competition
RSS: changes for this drugpriced separately — they are not the same market
Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $0.0301 · middle half $0.0301–$0.0301 · full range $0.0301–$0.0301 · 9 products · 23 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for levetiracetam, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- LevetiracetamSep 3, 2026Mfr enteredXGen Pharmaceuticals DJB, Inc. · levetiracetam
- LevetiracetamSep 3, 2026New productXGen Pharmaceuticals DJB, Inc.
- LevetiracetamAug 28, 2026New productDirect_Rx
- LevetiracetamAug 26, 2026Mfr enteredRemedyrepack Inc. · levetiracetam
- LevetiracetamAug 26, 2026Mfr enteredBaxter Healthcare Corporation · levetiracetam
- LevetiracetamAug 26, 2026New productRemedyrepack Inc.
- LevetiracetamAug 26, 2026New productBaxter Healthcare Corporation
- LevetiracetamAug 26, 2026New productBaxter Healthcare Corporation
- LevetiracetamAug 19, 2026Price upNADAC $0.15522 → $0.15657 per unit (+0.87%)
- LevetiracetamAug 19, 2026Price downNADAC $0.11324 → $0.11054 per unit (-2.38%)
Common questions
- Is Levetiracetam in shortage right now?
- No. FDA does not currently list Levetiracetam in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Levetiracetam?
- 118 companies have marketed Levetiracetam in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Levetiracetam cost?
- The typical pharmacy pays about $0.0739 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.